Nrx responds to relief's allegations of january 14, 2022

Radnor, pa., jan. 14, 2022 (globe newswire) -- nrx pharmaceuticals (nasdaq: nrxp), a clinical-stage biopharmaceutical company, responded to today's press release issued by relief therapeutics.

NRXP Ratings Summary

NRXP Quant Ranking